Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem; Jennifer Yost; Itziar Etxeandia-Ikobaltzeta; George M. Abraham; Janet A. Jokela; Matthew C. Miller; Mary Ann Forciea; Linda L. Humphrey; Mary Ann Forciea; Linda L. Humphrey; Adam J. Obley; Andrew Dunn; Robert M. Centor; Elie A. Akl; Thomas A. Bledsoe; Mary Ann Forciea; Ray Haeme; Janet A. Jokela; Devan L. Kansagara; Maura Marcucci; Mark P. Tschanz

doi:10.7326/L21-0607

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem^*
, Jennifer Yost
, Itziar Etxeandia-Ikobaltzeta
, George M. Abraham
, Janet A. Jokela
, Matthew C. Miller
, Mary Ann Forciea
, Linda L. Humphrey
, Mary Ann Forciea
, Linda L. Humphrey
, Adam J. Obley
, Andrew Dunn
, Robert M. Centor
, Elie A. Akl
, Thomas A. Bledsoe
, Mary Ann Forciea
, Ray Haeme
, Janet A. Jokela
, Devan L. Kansagara
, Maura Marcucci

Mark P. Tschanz

^*Corresponding author for this work

Internal Medicine

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	W116-W117
Journal	Annals of Internal Medicine
Volume	174
Issue number	12
DOIs	https://doi.org/10.7326/L21-0607
State	Published - 1 Dec 2021

Access to Document

10.7326/L21-0607

Cite this

Qaseem, A., Yost, J., Etxeandia-Ikobaltzeta, I., Abraham, G. M., Jokela, J. A., Miller, M. C., Forciea, M. A., Humphrey, L. L., Forciea, M. A., Humphrey, L. L., Obley, A. J., Dunn, A., Centor, R. M., Akl, E. A., Bledsoe, T. A., Forciea, M. A., Haeme, R., Jokela, J. A., Kansagara, D. L., ... Tschanz, M. P. (2021). Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Annals of Internal Medicine, 174(12), W116-W117. https://doi.org/10.7326/L21-0607

@article{15c854544d4849e4bd1476ed2ffaf777,

title = "Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)",

author = "Amir Qaseem and Jennifer Yost and Itziar Etxeandia-Ikobaltzeta and Abraham, \{George M.\} and Jokela, \{Janet A.\} and Miller, \{Matthew C.\} and Forciea, \{Mary Ann\} and Humphrey, \{Linda L.\} and Forciea, \{Mary Ann\} and Humphrey, \{Linda L.\} and Obley, \{Adam J.\} and Andrew Dunn and Centor, \{Robert M.\} and Akl, \{Elie A.\} and Bledsoe, \{Thomas A.\} and Forciea, \{Mary Ann\} and Ray Haeme and Jokela, \{Janet A.\} and Kansagara, \{Devan L.\} and Maura Marcucci and Tschanz, \{Mark P.\}",

year = "2021",

month = dec,

day = "1",

doi = "10.7326/L21-0607",

language = "English",

volume = "174",

pages = "W116--W117",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "12",

}

Qaseem, A, Yost, J, Etxeandia-Ikobaltzeta, I, Abraham, GM, Jokela, JA, Miller, MC, Forciea, MA, Humphrey, LL, Forciea, MA, Humphrey, LL, Obley, AJ, Dunn, A, Centor, RM, Akl, EA, Bledsoe, TA, Forciea, MA, Haeme, R, Jokela, JA, Kansagara, DL, Marcucci, M & Tschanz, MP 2021, 'Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)', Annals of Internal Medicine, vol. 174, no. 12, pp. W116-W117. https://doi.org/10.7326/L21-0607

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). / Qaseem, Amir; Yost, Jennifer; Etxeandia-Ikobaltzeta, Itziar et al.
In: Annals of Internal Medicine, Vol. 174, No. 12, 01.12.2021, p. W116-W117.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Update Alert 2

T2 - Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

AU - Qaseem, Amir

AU - Yost, Jennifer

AU - Etxeandia-Ikobaltzeta, Itziar

AU - Abraham, George M.

AU - Jokela, Janet A.

AU - Miller, Matthew C.

AU - Forciea, Mary Ann

AU - Humphrey, Linda L.

AU - Forciea, Mary Ann

AU - Humphrey, Linda L.

AU - Obley, Adam J.

AU - Dunn, Andrew

AU - Centor, Robert M.

AU - Akl, Elie A.

AU - Bledsoe, Thomas A.

AU - Forciea, Mary Ann

AU - Haeme, Ray

AU - Jokela, Janet A.

AU - Kansagara, Devan L.

AU - Marcucci, Maura

AU - Tschanz, Mark P.

PY - 2021/12/1

Y1 - 2021/12/1

UR - https://www.scopus.com/pages/publications/85122904196

U2 - 10.7326/L21-0607

DO - 10.7326/L21-0607

M3 - Letter

C2 - 34606308

AN - SCOPUS:85122904196

SN - 0003-4819

VL - 174

SP - W116-W117

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 12

ER -

Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Access to Document

Fingerprint

Cite this